Mantle Cell Lymphoma News and Research

RSS
Combination treatments reduce blood pressure in patients taking ibrutinib

Combination treatments reduce blood pressure in patients taking ibrutinib

Researchers find powerful combo weapon against aggressive lymphoma

Researchers find powerful combo weapon against aggressive lymphoma

New combination treatment offers hope for older patients with mantle cell lymphoma

New combination treatment offers hope for older patients with mantle cell lymphoma

Annual NCCN Congress to focus on latest advances in blood cancer treatment

Annual NCCN Congress to focus on latest advances in blood cancer treatment

Analyzing the role of LP-284 Hodgkin's lymphoma models and in DNA damage repair

Analyzing the role of LP-284 Hodgkin's lymphoma models and in DNA damage repair

University of Vermont Cancer Center to offer a novel, highly effective form of cancer treatment

University of Vermont Cancer Center to offer a novel, highly effective form of cancer treatment

Discovery could lead to new mantle cell lymphoma drugs

Discovery could lead to new mantle cell lymphoma drugs

Novel molecular imaging radiotracer can precisely diagnose multiple cancers

Novel molecular imaging radiotracer can precisely diagnose multiple cancers

Anonymous $5.75 million gift will enable UVA to fight against rare blood cancers

Anonymous $5.75 million gift will enable UVA to fight against rare blood cancers

How and when do de novo SARS-CoV-2 spike mutations emerge?

How and when do de novo SARS-CoV-2 spike mutations emerge?

Efficacy of COVID mRNA vaccines among patients on CAR‐T‐lymphocyte therapy

Efficacy of COVID mRNA vaccines among patients on CAR‐T‐lymphocyte therapy

Analysis finds variation in the management of mantle cell lymphoma across clinical settings

Analysis finds variation in the management of mantle cell lymphoma across clinical settings

Ibrutinib plus chemoimmunotherapy prolonged progression-free survival in previously untreated mantle cell lymphoma patients

Ibrutinib plus chemoimmunotherapy prolonged progression-free survival in previously untreated mantle cell lymphoma patients

Evaluating a third SARS-CoV-2 mRNA vaccine in anti-CD20-treated patients

Evaluating a third SARS-CoV-2 mRNA vaccine in anti-CD20-treated patients

New approach to CAR T-cell therapy for B-cell cancers triples the targeted antigens on cancer cells

New approach to CAR T-cell therapy for B-cell cancers triples the targeted antigens on cancer cells

CIRM awards $4.1 million to advance CAR T-cell therapy from the lab to clinic

CIRM awards $4.1 million to advance CAR T-cell therapy from the lab to clinic

New integrative NGS panel for analysis of standard and novel biomarkers in lymphoid neoplasms

New integrative NGS panel for analysis of standard and novel biomarkers in lymphoid neoplasms

Oral targeted therapy found to be an effective treatment option for high-risk hairy cell leukemia

Oral targeted therapy found to be an effective treatment option for high-risk hairy cell leukemia

Researchers discover new class of drugs that inhibits a 'master switch' in mantle cell lymphoma

Researchers discover new class of drugs that inhibits a 'master switch' in mantle cell lymphoma

Yale scientists uncover common mechanism that promotes autoimmune diseases and blood cancers

Yale scientists uncover common mechanism that promotes autoimmune diseases and blood cancers